What are you looking for? License Status VerificationAnnual/Quarterly ChecklistsFraud AssessmentsCompany LicensingApplying for Admission & ApplicationsRenewalsStatutory DepositsFeesLife and Health DivisionProduct FilingPharmacy Benefit Managers (PBM) Reports, New Mexico Health Access Survey, and BriefsContracted and External ReportsOSI Health Insurance BriefsThe 2023 New Mexico Health Access SurveyResource BinderConsumer Assistance Plan Continuous Quality ImprovementCoverage for Individuals with Diabetes (HB53)Cultural and Linguistic PlanDebt Collection Protection Act - Provider ResourceDental Provider CredentialingGuidance for CarriersHealth Rate ReviewManaged Health Care Compliance DeadlinesMember GrievanceMental Health ParityMonthly Member EnrollmentNetwork AdequacyPrescription Drug Price TransparencyProvider CredentialingProvider GrievanceRequest for Confidential StatusSmall Business Health Insurance Premium Relief InitiativeUtilization ManagementVaccine Purchasing ActProperty & CasualtyFinancial RegulationAccredited ReinsurersFinancial StatementsFinancial Statements ArchiveFinancial Examinations Financial Examinations ArchiveFinancial and Market Conduct Examinations - ArchiveTitle Insurance Forms & TablesASR USR Schedules & InstructionsStatistical ReportsIndividuals and AgenciesContinuing Education (CE)Criminal Offense Contact Rolanda Pana Phone: (505) 795-1495 rxtransparency@osi.nm.gov OSI Events Calendar View our calendar of events During the 2023 Legislative Session, the New Mexico State Legislature passed House Bill 33, the Prescription Drug Price Transparency Act. This legislation mandates the New Mexico Office of Superintendent of Insurance (OSI) to collect data from Drug Manufacturers, Pharmacy Services Administrative Organizations (PSAOs), authorized health insurers, and Pharmacy Benefit Managers (PBMs) regarding drug prices and sales. The law also requires OSI to report annually to legislative committees and the public. To fulfill this mandate, OSI will evaluate whether reporting entities meet the established reporting standards, analyze the data, and assess compliance with the Prescription Drug Price Transparency submission criteria. For additional information on these requirements, please refer to NMSA 1978, Section 59A-59A. Prescription Drug Price Transparency Reporting Tool Prescription Drug Price Transparency Act Submission Guidance 2026 (updated 02-24-2026) Prescription Drug Price Transparency Legislative Report 2025
August 11, 2026 Announcements ORDER ESTABLISHING PARAMETERS FOR DEFRAYAL UNDER 13.10.41 NMAC, COVERAGE FOR SPECIFICED SEX TRAIT MODIFICATION PROCEDURE Pursuant to NMSA, Section 59A-2-8 General powers and duties of superintendent, this order provides an initial interpretation of what specified sex trait modification procedures and prescriptions are eligible for defrayal starting Plan Year 2027 for health plans sold on the New Mexico BeWell Exchange. Office of Superintendent of Insurance (OSI) staff may revisit this interpretation […] Read More
June 22, 2026 Bulletins MEDICAL MALPRACTICE PREMIUM REDUCTION BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […] Read More
